Applied Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	11.95	79.4	49.9	16.66	53.89	57.47
Short-Term Investments	-	-	-	13.92	26.94	39.36
Cash & Short-Term Investments	11.95	79.4	49.9	30.58	80.82	96.83
Cash Growth	-87.92%	59.12%	63.17%	-62.16%	-16.53%	149.21%
Other Receivables	16.65	-	-	0.28	0.53	0.51
Receivables	16.65	-	-	0.28	0.53	0.51
Prepaid Expenses	1.26	1.74	1.35	2.12	2.56	2.91
Other Current Assets	1.8	2.51	3.13	4.33	4.48	2.35
Total Current Assets	31.65	83.65	54.39	37.31	88.39	102.59
Property, Plant & Equipment	2.47	2.79	0.45	0.86	1.3	1.71
Other Long-Term Assets	0.25	0.25	-	0.2	0.2	0.2
Total Assets	34.37	86.69	54.83	38.36	89.89	104.51
Accounts Payable	4.8	4.43	1.74	4.53	9.46	0.64
Accrued Expenses	7.37	15.33	13.93	13.65	14.78	18.56
Short-Term Debt	-	-	0.31	0.62	0.79	1.07
Current Portion of Leases	0.47	0.41	0.43	0.48	0.44	0.41
Current Unearned Revenue	0.21	0.21	0.67	-	-	-
Other Current Liabilities	20.06	6.92	54.1	14.14	0.99	0.55
Total Current Liabilities	32.9	27.3	71.18	33.42	26.46	21.24
Long-Term Leases	2.03	2.39	0.04	0.41	0.89	1.33
Other Long-Term Liabilities	-	-	0.76	0.46	-	-
Total Liabilities	34.94	29.69	71.98	34.3	27.35	22.57
Common Stock	0.04	0.04	0.01	0.01	0	0
Additional Paid-In Capital	635.76	631.18	451.43	352.83	328.96	242.78
Retained Earnings	-636.36	-574.21	-468.59	-348.82	-266.32	-160.73
Comprehensive Income & Other	-	-	-	0.05	-0.11	-0.11
Total Common Equity	-0.56	57.01	-17.15	4.06	62.54	81.94
Shareholders' Equity	-0.56	57.01	-17.15	4.06	62.54	81.94
Total Liabilities & Equity	34.37	86.69	54.83	38.36	89.89	104.51
Total Debt	2.5	2.8	0.78	1.51	2.12	2.81
Net Cash (Debt)	9.45	76.6	49.12	29.07	78.7	94.02
Net Cash Growth	-90.25%	55.95%	68.99%	-63.07%	-16.29%	155.38%
Net Cash Per Share	0.07	0.55	0.58	0.77	3.07	4.28
Filing Date Shares Outstanding	144.3	141.58	105.89	48.11	26.22	26.01
Total Common Shares Outstanding	144.3	137.23	84.87	48.06	26.22	22.49
Working Capital	-1.25	56.35	-16.8	3.88	61.93	81.36
Book Value Per Share	-0.00	0.42	-0.20	0.08	2.39	3.64
Tangible Book Value	-0.56	57.01	-17.15	4.06	62.54	81.94
Tangible Book Value Per Share	-0.00	0.42	-0.20	0.08	2.39	3.64

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q